Private equity firm New Mountain Capital has offered to purchase R1 RCM for $13....
Decades ago, Harvard botanist Richard Evans Schultes braved malaria and worse to...
Congress has abandoned its attempt to reform how PBMs operate in an upcoming pac...
The FDA is rescinding its approval of a blood cancer treatment from the Swedish ...
Oregon officials have suspended a portion of a contentious state law designed to...
A drug in development as a weight loss treatment succeeded in a Phase 2 study in...
Drugmakers are eyeing GLP-1 drugs, with their high levels of weight loss, as a p...
The movement to embrace state execution by means of nitrogen has a troubling new...
The upcoming Clinical Trial Supply Europe 2024 conference will round-up pharma a...
Merck's KEYTRUDA has received a positive opinion from the EMA CHMP for use in co...
SK bioscience has achieved a significant milestone with its typhoid conjugate va...
Moderna has announced the conclusion of construction works at its new mRNA manuf...
The US FDA has granted approval for Alvotech and Teva Pharmaceuticals’ SIMLANDI ...
Bayer’s oral tyrosine kinase inhibitor is currently in a Phase I trial estimated...
The Phase II prospective, randomised trial will evaluate three doses of PKM-01 t...
The EMA's decision on the marketing authorisation application for Biogen Qalsody...
